Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Elevance Health $1.8 billion senior notes offering
The investment-grade notes are due 2025, 2032 and 2052
Equinix $1.5 billion at-the-market offering
We advised the company on the SEC-registered at-the-market offering
Honeywell $2 billion senior notes offering
The investment-grade notes are due 2024, 2028 and 2033
Honeywell €1 billion senior notes offering
The investment-grade notes are due 2034
Oesterreichische Kontrollbank $1 billion notes offering
The notes are due 2025
TIAA sale of TIAA Bank
We are advising TIAA on the transaction
NextGen Healthcare $275 million convertible senior notes offering
The 3.75% convertible notes are due 2027
Marsh McLennan $1 billion senior notes offering
We advised Marsh McLennan on its investment-grade notes offering
Verisk $3.1 billion sale of Wood Mackenzie to Veritas Capital
We are advising Verisk on the transaction
Elon Musk $13.2 billion Twitter acquisition financing
We advised the agent, joint lead arrangers and initial lenders on the financing